Palobiofarma S.L.
Advancing healthcare through innovative adenosine receptor-based drugs
General Information
BounceWatch is an independent company data service, not affiliated with Palobiofarma S.L.. To contact Palobiofarma S.L., visit palobiofarma.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About Palobiofarma S.L.
Taxonomy: Biopharmaceutical, Drug discovery, Adenosine receptors, Innovation, Biotech company, Medical research, Barcelona Science Park, European drug discovery, Spanish company
Funding Rounds & Investors (6)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | €7.00M | 3 |
|
02 Feb 2024 |
| Convertible Note | Undisclosed | 1 |
The Foundation for Prader-Willi Research
|
04 May 2023 |
| Grant | €2.50M | 1 |
|
06 Oct 2021 |
| Venture Round | Undisclosed | 1 |
|
06 Oct 2021 |
| Series A | €4.50M | 2 |
|
19 Jun 2013 |
| Seed Round | €2.00M | 1 |
|
15 Jul 2010 |
Palobiofarma S.L. Alternatives & Competitors
View All Alternatives
We develop precision medicines for rare and refractory epilepsy.
-logo.jpg "InnoCare Pharma"){kind=logo}
Science drives innovation for the benefit of patients!
Advancing innovative health solutions by targeting the endocannabinoid system to enhance metabolic a...
FAQ About Palobiofarma S.L.
Source: BounceWatch company record for Palobiofarma S.L., https://bouncewatch.com/company/palobiofarma, updated 20 December 2024. When citing, please name BounceWatch and link this page.
